Sigma Planning Corp Has $843,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Sigma Planning Corp lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 10.0% in the fourth quarter, Holdings Channel reports. The firm owned 6,373 shares of the financial services provider’s stock after selling 710 shares during the period. Sigma Planning Corp’s holdings in iShares Biotechnology ETF were worth $843,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets lifted its holdings in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Commerce Bank raised its holdings in iShares Biotechnology ETF by 1.8% during the 3rd quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after buying an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 2.5% in the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after buying an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $18,476,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $137.86 on Wednesday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company’s fifty day simple moving average is $135.64 and its 200 day simple moving average is $140.74.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.